1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. Japan >
  6. Santen Pharmaceutical >
  7. M&A

Santen Pharmaceutical Mergers & Acquisitions

Santen Pharmaceutical M&A Summary

Santen Pharmaceutical has acquired 3 companies, including 1 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.

Santen Pharmaceutical’s largest acquisition to date was in 2016, when it acquired InnFocus for $225M. Santen Pharmaceutical has acquired in 2 different US states, and 2 countries. The Company’s most targeted sectors include healthcare services (34%) and life science (34%).

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity3
    • M&A Sell Activity1
  • Total Sectors Invested 3
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 3

Santen Pharmaceutical

Santen Pharmaceutical Co. Ltd.

Grand Front Osaka Tower A,
Osaka, 530-8552
Japan,
+81 6 7664 8621
www.santen.com

All (4) Buy (3) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2023-07-18 Santen - Branded Ophthalmic Portfolio · Life Science
Osaka, Japan

Santen’s Branded Ophthalmic Portfolio Includes U.S. and Canadian commercial rights to Flarex, natacyn, tobradex st, verkazia, zerviate, and non-prescription brands freshkote and cationorm plus.

- Divestiture

Harrow

Santen Pharmaceutical


Try Mergr Free — See This and 221,292+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal